Skip to main content
OpenTrials

Clinical trial condition

Chronic Spontaneous Urticaria

Explore clinical trials studying Chronic Spontaneous Urticaria. Study availability and eligibility vary by location and protocol.

69 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Chronic Spontaneous Urticaria trial results

Completed

Study to Investigate the Efficacy and Safety of QGE031 in Adolescent Patients With Chronic Spontaneous Urticaria (CSU)

NCT03437278

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Novartis Investigative Site Rosario, Santa Fe Province, Argentina
  • Novartis Investigative Site Bahía Blanca, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Brussels, Belgium
View all 20 locations
View Trial Details
Completed

Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment

NCT06228560

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of China Medical University Beijing, Beijing Municipality, China
View all 20 locations
View Trial Details
Completed

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids)

NCT05526521

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Pediatric Dermatology of Miami Site Number : 8400015 Coral Gables, Florida, United States
  • Treasure Valley Medical Research Site Number : 8400019 Boise, Idaho, United States
  • Washington University School of Medicine- Site Number : 8400004 St Louis, Missouri, United States
  • Boston Childrens Health Physicians Site Number : 8400017 Hawthorne, New York, United States
View all 15 locations
View Trial Details
Completed

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

NCT05795153

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Acuro Research Inc Little Rock, Arkansas, United States
  • Florida Ctr Allergy Asthma Research Aventura, Florida, United States
  • Finlay Medical Research Greenacres City, Florida, United States
  • Treasure Valley Medical Research Boise, Idaho, United States
View all 44 locations
View Trial Details
Completed

Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001

NCT06577116

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • Site 601-004 Birmingham, Alabama, United States
  • Site 601-014 Bakersfield, California, United States
  • Site 601-015 Upland, California, United States
  • Site 601-006 Overland Park, Kansas, United States
View all 14 locations
View Trial Details
Completed

Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID)

NCT04180488

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +10 more
Locations
  • California Allergy and Asthma Medical Group, Inc. Site Number : 8400019 Los Angeles, California, United States
  • Sarasota Clinical Research Site Number : 8400017 Sarasota, Florida, United States
  • Lenus Research & Medical Group Site Number : 8400001 Sweetwater, Florida, United States
  • University of South Florida Site Number : 8400006 Tampa, Florida, United States
View all 98 locations
View Trial Details
Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria

NCT06072157

Conditions
Chronic Disease, Chronic Spontaneous Urticaria, Chronic Urticaria, +11 more
Locations
  • Site 601-001 Healthy Volunteer Clinical Research Unit (Part A, B and D) Anniston, Alabama, United States
  • Site 601-004 (Part C) Birmingham, Alabama, United States
  • Site 601-008 (Part C) Scottsdale, Arizona, United States
  • Site 601-014 (Part C) Bakersfield, California, United States
View all 25 locations
View Trial Details

Related conditions